Document:

Unassociated Document

Exhibit 10.1

 

 

Property Borrowing Agreement

Party A: Zhao Dong Ke

 

 

Party B: Yangling Dongke Maidisen Pharmaceutical Co., Ltd.

 

In order to support the development of Party B, Party A voluntarily lend one of his house property to party B, the two sides reached the following agreement:

 

1.Location of Party B’s house property: Dongxing Science and Technology Building, No.1 Xin Ke Road in xi’an city. areas: 1600m2. State: full-decoration office building.

 

2.the house property which Party A lends to Party B is limited to meet Party B’s business needs which caused by removing its sales and management departments from the factory location to xi’an and Party 

B’s fast-growing market networking needs. Party B has no right to change the use and structure of the Party A’s house property.

 

3. Time Limit: January 1, 2007 to December 31, 2011.

 

4, Costs Agreement: free of charge for five years.

 

Party A

 

By: /s Zhao Dongke

Zhao Dongke

 

Party B

By: /s Zheng Liming

 Zheng Liming

 

Seal: Yangling Dongke Maidisen Pharmaceutical Co., Ltd

 

 Signing Date: December 26, 2006Unassociated Document

Exhibit 10.2

 

 

REFERRAL AGREEMENT

 

This Referral Agreement ("Agreement"), dated January 7, 2010, is made by and between:

 

 

	  	
Jinhao Zhang 

2-31 Tian Yuan Ju Wei Er Road

Yangling District

Xianyang, Shaanxi Province, P.R.C.

 

       and

	
("Referrer")

	  	  	  
	  	
Dong Ke Pharmaceutical Inc. 

No.8 of Xinqiao Road

Yangling High-tech of Agriculture Demonstration Region

Xi'an, Shaanxi Province, P.R.C.

 

	
(the “Principal”)

 

RECITALS

WHEREAS, Principal is interested in merging with said public shell.

NOW, THEREFORE, in consideration for those services Referrer provides to Principal, the parties agree as follows:

 

1.    INDEPENDENT CONTRACTOR: Nothing in this agreement shall be construed to create the relationship of employer and employee, joint venture, or partnership, between parties hereto. Referrer shall be deemed at all times to be an Independent Contractor.

 

2.    UNIQUE SERVICES PROVIDED: The scope of this agreement is limited and unique to the Referrer to perform for the Principal such services.

 

a)     To provide the Principal certain information regarding an over-the-counter bulletin board (“OTCBB”) public shell so that Principal may complete necessary ‘due diligence’ for a potential acquisition of or merger with such shell. Specifically and at minimum, the Referrer shall provide the publicly-traded ticker symbol and contact information for the current majority shareholder, and officer(s) and director(s).

 

3.    COMPENSATION: Principal agrees to pay Referrer, as his fee and in consideration for the referral services to be performed by Referrer under this Agreement, the Company will issue the Referrer warrants to acquire 1,000,000 common shares of the Company’s common stock, subject to any forward or reverse splits, with registration rights, at a $1.00 exercise price and expiration date of three years after acquiring control of or merging with said public shell for time spent on Referral Services, at the time of acquiring control or merging with said public shell.  (collectively, the “Warrants”)

 

4.    TERM: Referrer shall begin services for the Principal on January 7, 2009. Services will continue in perpetuity unless terminated as a result of the Principal, his agents, his clients, or his nominees merging with the referred OCTBB company to the Principal by the Referrer and completing the payment of compensation as agreed.

 

 

5.    ASSIGNMENT: Both parties shall not be entitled to assign or transfer this agreement without prior consent from the other party in writing.

6.    LIMITATIONS: Principal will only be responsible to compensate Referrer in the event that the Principal, his agents, his clients, or his nominees, executes an agreement to merge with a specific OTCBB company referred to the Principal by the Referrer. Referrer holds no obligations to the Principal other than to have provided the unique services one (1) time.

7.     GOVERNING LAW: This Agreement shall be governed by the interpreted in accordance with the laws of the State of Delaware without reference to its conflicts of laws rules or principles. Each of the parties consents to the exclusive jurisdiction of the superior courts of the Laws of Delaware in connection with any dispute arising under this Agreement and hereby waives, to the maximum extent permitted by law, any objection, including any objection based on forum non convenes, to the bringing of any such proceeding in such jurisdictions.

 

 

 

  

  

  

 

 

8.     INDIVIDUAL AGREEMENT: This Agreement is separate and unique from any past, present, or future agreements entered between the Referrer and Principal. Both parties agree that their signatures below represent their true identity as provided in government-issued identification documents.

9.     REGISTRATION RIGHTS:  The Company will cause a registration statement to be filed with the U.S. Securities and Exchange Commission, covering 100% of the common stock underlying the Warrants, on or before three months after the close of the acquiring control of or merging with said public shell and use its commercially reasonable efforts to cause the registration statement to become effective within one hundred twenty (120) days following the date of the filing of the registration statement.  The Company will also use commercially reasonable efforts to maintain the effectiveness of the registration statement for a period of 3 years from the date of acquiring control of or merging with said public shell.

The Company will be deemed not to have used commercially reasonable efforts to cause the registration statement to become, or to remain effective during the requisite period if the Company voluntarily takes any action that would, or omits any action the omission of which would result in either: (i) such registration statement not being declared effective; or (ii) the holders of securities covered by a previously effective registration statement being prohibited by applicable law from trading the securities covered thereby.

10.     NON-DISCLOSURE and CONFIDENTIALITY:

 

BASIS FOR CONFIDENTIAL TREATMENT: It is recognized that such information passed in-between parties has substantial competitive value so long as it is withheld from public dissemination, and this value will be impaired or destroyed on publication or disclosure to others. Accordingly, all information exchanged under this Agreement shall be considered to be proprietary information. During the term of this Agreement, each receiving party will make all reasonable efforts to protect the information disclosed, or exchanged, relative to the subject matter specified below. In no event shall either party, without the prior written approval of the other party, (a) make such information or documents available to any third party, or (b) disclose or identify the source of any of the information disclosed in confidence.

By: /s/ Jinhao Zhang

Jinhao Zhang

Dong Ke Pharmaceutical Inc.Unassociated Document

Exhibit 10.3

 

This Consulting Agreement (the "Agreement") is entered into this 9th day of March, 2010 by and between:

 

	 NSD Consulting Services, Inc., 	  (the “Consultant”)	 
	 Suite 501, 250 West 57th	 	 
	 New York, NY, 10019	 	 
	 	 	 
	 and	 	 
	 	 	 
	Dong Ke Pharmaceutical, Inc., a Delaware Corporation 	 (the “Company”)	 
	No.8 of Xinqiao Road	 	 
	Yangling High-Tech of Agriculture Demonstration Region	 	 
	 Xi'an, Shaanxi Province, P.R.C.	 	 

 

RECITALS

WHEREAS, the Company is in need of assistance in the public company sector including advising on a merger/acquisition transaction, NASDAQ and Hong Kong Stock Exchange listing applications, SEC filings including but not limited to, Form 8-K, Registration Statement support;

WHEREAS, the Consultant has agreed to perform consulting work for the Company in providing merger/acquisition transaction support, NASDAQ and Hong Kong Stock Exchange listing applications support, SEC filings, including but not limited to, Form 8K and Registration Statement support and other consulting services and other related activities as directed by the Company;  and

NOW, THEREFORE, the parties hereby agree as follows:

1. Consultant's Services. Consultant shall be available and shall provide to the Company professional consulting services in the areas of merger/acquisition transaction support, NASDAQ and Hong Kong Stock Exchange listing applications support SEC filings, including but not limited to, Form 8K and Registration Statement support and other consulting services support ("Consulting services") as requested.

2. Consideration.

A. RATE.  In consideration for the Consulting Services to be performed by Consultant under this Agreement, the Company will issue the Consultant warrants to acquire 72,727 common shares of the Company’s stock, adjusted for any forward or reverse splits, with registration rights, at a $13.75 exercise price and expiration date of three years after the closing of the acquisition or merger for time spent on Consulting Services.  (collectively, the “Warrants”)

B.  EXPENSES. Additionally, the Company will pay Consultant only for the following pre-approved expenses incurred while the Agreement between Consultant and the Company exists:

	
·  

	
All travel expenses to and from all work sites

	
·  

	
Meal expenses;

	
·  

	
Administrative expenses;

	
·  

	
Lodging Expenses if work demands overnight stays; and

	
·  

	
Miscellaneous travel-related expenses (parking and tolls).

Consultant shall submit written documentation and receipts where available itemizing the dates on which expenses were incurred. The Company shall pay Consultant the pre-approved amounts due pursuant to submitted reports within 14 days after a report is received by the Company.

 

 

  

  

  

 

 

 

C. REGISTRATION RIGHTS: The Company will cause a registration statement to be filed with the U.S. Securities and Exchange Commission, covering 100% of the common stock underlying the Warrants, on or before September 9, 2010 and use its commercially reasonable efforts to cause the registration statement to become effective within one hundred eighty (180) days following the date of this Agreement.  The Company will also use commercially reasonable efforts to maintain the effectiveness of the registration statement for a period of 3 years from the date of this Agreement

The Company will be deemed not to have used commercially reasonable efforts to cause the registration statement to become, or to remain effective during the requisite period if the Company voluntarily takes any action that would, or omits any action the omission of which would result in either: (i) such registration statement not being declared effective; or (ii) the holders of securities covered by a previously effective registration statement being prohibited by applicable law from trading the securities covered thereby.

D. SENIOR EXCHANGE LISTING: The Company will cause a listing application to be filed with the NASDAQ Exchange for the Capital Markets board within 9 months following the closing of the acquisition or merger. The Company will maintain or ensure by reverse split that the share BID will remain at $4.00 within 9 months following the date of the closing of the acquisition or merger.  The Company will use commercially reasonable efforts to maintain the company in good standing and in good structure to meet the listing requirements of NASDAQ’s Capital Market.

3. Independent Contractor.  Nothing herein shall be construed to create an employer-employee relationship between the Company and Consultant. Consultant is an independent contractor and not an employee of the Company or any of its subsidiaries or affiliates. The consideration set forth in Section 2 shall be the sole consideration due Consultant for the services rendered hereunder. It is understood that the Company will not withhold any amounts for payment of taxes from the compensation of Consultant hereunder. Consultant will not represent to be or hold herself out as an employee of the Company.

4. Confidentiality.  In the course of performing Consulting Services, the parties recognize that Consultant may come in contact with or become familiar with information which the Company or its subsidiaries or affiliates may consider confidential. This information may include, but is not limited to, information pertaining to the Company [specify] systems, which information may be of value to a competitor. Consultant agrees to keep all such information confidential and not to discuss or divulge it to anyone other than appropriate Company personnel or their designees.

5. Term. This Agreement shall commence on March 9, 2010 and shall terminate on a March 9, 2012, unless earlier terminated by either party hereto. Either party may terminate this Agreement upon Thirty (30) days prior written notice. The Company may, at its option, renew this Agreement for an additional One (1) year term on the same terms and conditions as set forth herein by giving notice to Consultant of such intent to renew on or before March 9, 2012.

6. Notice.  Any notice or communication permitted or required by this Agreement shall be deemed effective when personally delivered or deposited, postage prepaid, in the first class mail of the United States properly addressed to the appropriate party at the address set forth below:

Notices to Consultant:

NSD Consulting Services, Inc.

Suite 501, 250 West 57th

New York, NY, 10019

Notices to the Company:

Dong Ke Pharmaceutical, Inc.

No.8 of Xinqiao Road

Yangling High-tech of Agriculture Demonstration Region

Xi'an, Shaanxi Province, P.R.C.

 

 

  

  

  

 

 

7. Miscellaneous.

7.1 Entire Agreement and Amendments.  This Agreement constitutes the entire agreement of the parties with regard to the subject matter hereof, and replaces and supersedes all other agreements or understandings, whether written or oral. No amendment or extension of the Agreement shall be binding unless in writing and signed by both parties.

7.2 Binding Effect, Assignment.  This Agreement shall be binding upon and shall inure to the benefit of Consultant and the Company and to the Company's successors and assigns. Nothing in this Agreement shall be construed to permit the assignment by Consultant of any of its rights or obligations hereunder, and such assignment is expressly prohibited without the prior written consent of the Company.

7.3 Governing Law, Severability.  This Agreement shall be governed by the laws of the New York. The invalidity or unenforceability of any provision of the Agreement shall not affect the validity or enforceability of any other provision.

WHEREFORE, the parties have executed this Agreement as of the date first written above.

Dong Ke Pharmaceutical, Inc.:

By: /s/ Dongke Zhao

Dongke Zhao, Chief Executive Officer

Date: March 9, 2010

NSD Consulting Services, Inc.,

By: /s/ Benjamin Lai

Benjamin Lai, President

March 9, 2010

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00173-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00173-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00173-of-00352.parquet"}]]